On September 18, 2023, Mr. David Seligman notified G Medical Innovations Holdings Ltd. (the "Company") of his
resignation as the chief financial officer of the Company, effective on November 18, 2023. Mr. Seligman's
resignation was not related to any disagreement with the Company on any matter relating to its operations,
policies or practices. On September 20, 2023, the board of directors of the Company approved the appointment of Mr. Kobi Ben-Efraim as the Company's chief financial officer, effective on November 18, 2023 and approved the terms of his compensation. Mr. Ben-Efraim has served as the Company's Chief Financial Officer from January 2015 to June 1, 2022, and has
been serving as the Company's Controller since June 1, 2022. From 2003 to 2014, Mr. Ben-Efraim served as the
chief financial officer at LifeWatch AG. Prior to that, from 1996 until 2000, Mr. Ben-Efraim served in various capacities at DSPC Group, including chief accountant. Mr. Ben-Efraim is a Certified Public Accountant in Israel. Mr. Ben-Efraim holds a B.A. in Economics and Accounting from Tel Aviv University.